U.S., May 22 -- ClinicalTrials.gov registry received information related to the study (NCT06983691) titled 'Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib' on May 14.
Brief Summary: The goal of this study is to test a novel nurse-delivered patient navigation program for women with HER2+ metastatic breast cancer (mBC) receiving tucatinib, trastuzumab, and capecitabine. The program will focus on enhancing understanding of the treatment regimen, managing symptoms and adherence, and improving coping and self-management skills. If successful, the program could be integrated into clinical care to better support mBC patients. The main question the study aims to answer is: is the patient navigation program fe...